Therapeutic drug monitoring to personalize dosing of imatinib, sunitinib, and pazopanib: A mixed methods study on barriers and facilitators by Kim Westerdijk, Neeltje Steeghs, Casper S. J. Tacke, Winette T. A. van derGraaf, Nielka P. vanErp, Gerard vanOortmerssen, Rosella P. M. G. Hermens, Ingrid M. E. Desar, In collaboration with the Dutch Pharmacology Oncology Group (DPOG)

Get full text